Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

[Treatment of elderly patients with non-Hodgkin's lymphoma].

Titorenko IB, Kriachok IA.

Lik Sprava. 2011 Jul-Sep;(5-6):79-85. Ukrainian.

PMID:
22606896
2.

Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.

Sonneveld P, Hop W, Mulder AH, Michiels JJ, Blijham G, van de Lelie J, Raemakers JW, Nieuwenhuis K, van der Heul C.

Semin Hematol. 1994 Apr;31(2 Suppl 3):9-12. No abstract available.

PMID:
8073309
3.

CHOP versus CNOP (N = mitoxantrone) in non-Hodgkin's lymphoma: an interim report comparing efficacy and toxicity.

Brusamolino E, Bertini M, Guidi S, Vitolo U, Inverardi D, Merante S, Colombo A, Resegotti L, Bernasconi C, Ferrini PR, et al.

Haematologica. 1988 May-Jun;73(3):217-22. No abstract available.

PMID:
3139519
4.

Results of a randomized study of previously-untreated intermediate and high grade lymphoma using CHOP versus CNOP.

Pavlovsky S, Santarelli MT, Erazo A, Diaz Maqueo JC, Somoza N, Lluesma Goñalons M, Cervantes G, Garcia Vela EL, Corrado C, Magnasco H, et al.

Ann Oncol. 1992 Mar;3(3):205-9.

PMID:
1586618
5.

[A comparative trial of C-novantrone OP(CNOP) vs C-adriamycin OP(CHOP) in the treatment of stage II-IV malignant lymphoma--the preliminary report].

Chuang MW, Tzeng CH, Chiou TJ, Chiu CF, Hsieh RK, Liu JH, Chen PM.

Zhonghua Yi Xue Za Zhi (Taipei). 1988 Jan;41(1):51-6. Chinese. No abstract available.

PMID:
3167650
6.

Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

Wunderlich A, Kloess M, Reiser M, Rudolph C, Truemper L, Bittner S, Schmalenberg H, Schmits R, Pfreundschuh M, Loeffler M; German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

Ann Oncol. 2003 Jun;14(6):881-93.

PMID:
12796026
7.

Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.

Sonneveld P, de Ridder M, van der Lelie H, Nieuwenhuis K, Schouten H, Mulder A, van Reijswoud I, Hop W, Lowenberg B.

J Clin Oncol. 1995 Oct;13(10):2530-9.

PMID:
7595704
8.

Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma.

Picozzi VJ, Pohlman BL, Morrison VA, Lawless GD, Lee MW, Kerr RO, Ford JM, Delgado DJ, Fridman M, Carter WB.

Oncology (Williston Park). 2001 Oct;15(10):1296-306; discussion 1310-1, 1314.

9.

Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate- and high-grade non-Hodgkin's lymphomas. Novantrone International Study Group.

Bezwoda W, Rastogi RB, Erazo Valla A, Diaz-Maqueo JC, Pavlovsky S, Morioka H, Resegotti L, Rueckle H, Somoza N, Moreno-Nogueira JA, et al.

Eur J Cancer. 1995 Jun;31A(6):903-11.

PMID:
7646919
12.

Non-Hodgkin's lymphoma in the elderly. Part 2: treatment of diffuse aggressive lymphomas.

Morrison VA.

Oncology (Williston Park). 2007 Sep;21(10):1191-8; discussion 1198-1208, 1210. Review.

14.

Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma.

Visani G, Guiducci B, D'Adamo F, Mele A, Nicolini G, Leopardi G, Sparaventi G, Barulli S, Malerba L, Isidori A, Malagola M, Piccaluga PP.

Leuk Lymphoma. 2005 Mar;46(3):477-9. No abstract available.

PMID:
15621843
15.

Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.

Itoh K, Ohtsu T, Fukuda H, Sasaki Y, Ogura M, Morishima Y, Chou T, Aikawa K, Uike N, Mizorogi F, Ohno T, Ikeda S, Sai T, Taniwaki M, Kawano F, Niimi M, Hotta T, Shimoyama M, Tobinai K; Members of the lymphoma study group of the Japan Clinical Oncology Group (JCOG).

Ann Oncol. 2002 Sep;13(9):1347-55.

PMID:
12196359
18.
19.

CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis).

Björkholm M, Andersson T, Ahlbom A, Ösby E.

Eur J Haematol. 2008 Jun;80(6):477-82. doi: 10.1111/j.1600-0609.2008.01062.x. Epub 2008 Mar 10. Erratum in: Eur J Haematol. 2011 Sep;87(3):285. Magnus, Björkholm [corrected to Björkholm, Magnus]; Tomas, Andersson [corrected to Andersson, Tomas]; Anders, Ahlbom [corrected to Ahlbom, Anders]; Eva, Osby [corrected to Ösby, Eva].

PMID:
18331601
20.

Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.

Mori M, Kitamura K, Masuda M, Hotta T, Miyazaki T, Miura AB, Mizoguchi H, Shibata A, Saito H, Matsuda T, Masaoka T, Harada M, Niho Y, Takaku F.

Int J Hematol. 2005 Apr;81(3):246-54.

PMID:
15814336

Supplemental Content

Support Center